| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |